Inactive Instrument

Forest Laboratories, Inc. Share Price

Stocks

End-of-day quote NYSE
- ^USD	-

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
14/04/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
10/04/14	Icahn backs down from demand that eBay spin off PayPal	RE
20/02/14	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/02/14	Icahn says Actavis-Forest deal validates shareholder activism	RE
18/02/14	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
08/01/14	S&P 500 ends flat in wake of Fed minutes	RE
08/01/14	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/01/14	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
23/10/13	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

30/06/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
23/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
20/06/14	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

17/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/04/14	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-1.64%	+1.16%	+54.09%	+109.07%	1,026B
JOHNSON & JOHNSON	-0.01%	+0.71%	+52.44%	+67.71%	649B
ABBVIE INC.	-0.05%	+0.98%	+19.08%	+73.55%	468B
ROCHE HOLDING AG	-0.29%	+0.17%	+39.21%	+44.98%	352B
NOVARTIS AG	+0.98%	+2.26%	+21.27%	+28.26%	271B
ASTRAZENECA PLC	-0.47%	-0.48%	+10.33%	+10.49%	256B
AMGEN INC.	-1.01%	+7.90%	+41.59%	+51.70%	220B
GILEAD SCIENCES, INC.	-0.85%	+2.50%	+32.32%	+101.80%	188B
NOVO NORDISK A/S	-1.25%	-10.72%	-32.88%	-60.86%	170B
Average	-0.20%	+1.26%	+26.38%	+47.41%	399.9B
Weighted average by Cap.	+0.10%	+1.26%	+36.19%	+65.73%

Employees

Sector